Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Paloma Montero Escribano"'
Autor:
Óscar Fernández Fernández, Lucienne Costa-Frossard, Maria Luisa Martínez Ginés, Paloma Montero Escribano, José María Prieto González, Lluís Ramió-Torrentà, Yolanda Aladro, Ana Alonso Torres, Elena Álvarez Rodríguez, Andrés Labiano-Fontcuberta, Lamberto Landete Pascual, Ambrosio Miralles Martínez, Ester Moral Torres, Pedro Oliva-Nacarino
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionThe Spasticity-Plus Syndrome (SPS) in multiple sclerosis (MS) refers to a combination of spasticity and other signs/symptoms such as spasms, cramps, bladder dysfunction, tremor, sleep disorder, pain, and fatigue. The main purpose is to de
Externí odkaz:
https://doaj.org/article/60412756c06b4332b1107302498e9bb2
Autor:
Natalia Villar-Gómez, Doddy Denise Ojeda-Hernandez, Eneritz López-Muguruza, Silvia García-Flores, Natalia Bonel-García, María Soledad Benito-Martín, Belen Selma-Calvo, Alejandro Arturo Canales-Aguirre, Juan Carlos Mateos-Díaz, Paloma Montero-Escribano, Jordi A. Matias-Guiu, Jorge Matías-Guiu, Ulises Gómez-Pinedo
Publikováno v:
Cells, Vol 11, Iss 19, p 3095 (2022)
Neurological disorders are a leading cause of morbidity worldwide, giving rise to a growing need to develop treatments to revert their symptoms. This review highlights the great potential of recent advances in cell therapy for the treatment of neurol
Externí odkaz:
https://doaj.org/article/2e31cb8333154ab08d998d4d7fc866e5
Autor:
Alfonso Delgado-Álvarez, Jordi A. Matias-Guiu, Cristina Delgado-Alonso, Laura Hernández-Lorenzo, Ana Cortés-Martínez, Lucía Vidorreta, Paloma Montero-Escribano, Vanesa Pytel, Jorge Matias-Guiu
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Background: Verbal fluency (VF) has been associated with several cognitive functions, but the cognitive processes underlying verbal fluency deficits in Multiple Sclerosis (MS) are controversial. Further knowledge about VF could be useful in clinical
Externí odkaz:
https://doaj.org/article/00e5be4d5def4964b138aff439a666ac
Autor:
Jorge Matías-Guiu, Jordi A. Matías-Guiu, Paloma Montero-Escribano, Juan A. Barcia, Alejandro A. Canales-Aguirre, Juan C. Mateos-Diaz, Ulises Gómez-Pinedo
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
The repair of demyelinated lesions is a key objective in multiple sclerosis research. Remyelination fundamentally depends on oligodendrocyte progenitor cells (OPC) reaching the lesion; this is influenced by numerous factors including age, disease pro
Externí odkaz:
https://doaj.org/article/3f112d4f2457472491dab31822b5a8bb
Autor:
Ulises Gómez-Pinedo, Jordi A. Matías-Guiu, María Soledad Benito-Martín, Lidia Moreno-Jiménez, Inmaculada Sanclemente-Alamán, Belen Selma-Calvo, Sara Pérez-Suarez, Francisco Sancho-Bielsa, Alejandro Canales-Aguirre, Juan Carlos Mateos-Díaz, Mercedes A. Hernández-Sapiéns, Edwin E. Reza-Zaldívar, Doddy Denise Ojeda-Hernández, Lucía Vidorreta-Ballesteros, Paloma Montero-Escribano, Jorge Matías-Guiu
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 19, p 10738 (2021)
Oligodendrocyte precursor cell (OPC) migration is a mechanism involved in remyelination; these cells migrate from niches in the adult CNS. However, age and disease reduce the pool of OPCs; as a result, the remyelination capacity of the CNS decreases
Externí odkaz:
https://doaj.org/article/4c4e5050747b4a5086512dfb2d4f00f2
Autor:
Ulises Gómez-Pinedo, Yolanda García-Ávila, Lucía Gallego-Villarejo, Jordi A. Matías-Guiu, María Soledad Benito-Martín, Noelia Esteban-García, Inmaculada Sanclemente-Alamán, Vanesa Pytel, Lidia Moreno-Jiménez, Francisco Sancho-Bielsa, Lucía Vidorreta-Ballesteros, Paloma Montero-Escribano, Jorge Matías-Guiu
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10, p 5192 (2021)
Introduction: AQP4 (aquaporin-4)–immunoglobulin G (IgG)-mediated neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disease that affects the central nervous system, particularly the spinal cord and optic nerve; remyelin
Externí odkaz:
https://doaj.org/article/952e259f88ee49c1a2d4f8c7b87e1ea1
Autor:
Alfonso Delgado-Álvarez, María Díez-Cirarda, Cristina Delgado-Alonso, Laura Hernández-Lorenzo, Constanza Cuevas, María Valles-Salgado, Paloma Montero-Escribano, María José Gil-Moreno, Jorge Matías-Guiu, Rocío García-Ramos, Jordi A. Matias-Guiu
Publikováno v:
Journal of Alzheimer's disease : JAD.
Background: The Rowland Universal Dementia Assessment Scale (RUDAS) is a cognitive test with favorable diagnostic properties for detecting dementia and a low influence of education and cultural biases. Objective: We aimed to validate the RUDAS in peo
Autor:
Ulises Gómez-Pinedo, Jordi A. Matías-Guiu, Denise Ojeda-Hernandez, Sarah de la Fuente-Martin, Ola Mohamed-Fathy Kamal, Maria Soledad Benito-Martin, Belen Selma-Calvo, Paloma Montero-Escribano, Jorge Matías-Guiu
Publikováno v:
Cells. 12:1515
The implantation of oligodendrocyte precursor cells may be a useful therapeutic strategy for targeting remyelination. However, it is yet to be established how these cells behave after implantation and whether they retain the capacity to proliferate o
Autor:
Alfonso Delgado-Álvarez, Cristina Delgado-Alonso, Miriam Goudsmit, María José Gil, María Díez-Cirarda, María Valles-Salgado, Paloma Montero-Escribano, Laura Hernández-Lorenzo, Jorge Matías-Guiu, Jordi A Matias-Guiu
Publikováno v:
Multiple sclerosis and related disorders. 67
Several batteries have been developed for the cognitive assessment of people with multiple sclerosis (MS). However, all these tests have some limitations in general clinical practice and from a cross-cultural perspective. In this study, we aimed to v
Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F
Autor:
Alfonso Delgado-Álvarez, Jordi A Matías-Guiu, Cristina Delgado-Alonso, Constanza Cuevas, Marta Palacios-Sarmiento, Lucía Vidorreta-Ballesteros, Paloma Montero-Escribano, Jorge Matías-Guiu
Publikováno v:
Multiple sclerosis and related disorders. 63
Fatigue is one of the most common symptoms in neurology, especially in MS patients with a prevalence of 65%. It is described as the most disabling symptom by 40% of MS patients. This study aimed to validate the Functional Assessment of Chronic Illnes